23andMe
efficiently develop novel therapeutics by power need and speed mes gee | 23andMe
Company
Deck Type
Sector
Industry
Deck date
February 2021
Slide
27 of 47
Similar slides by 23andMe
See diffirences between slides (animation)
Investor Presentation
August 2022
potential to more efficiently develop novel therapeutics by power need and speed | 23andMe
Investor Presentation
February 2022
potential to more efficiently develop novel therapeutics by power need and speed years average ates years | 23andMe
Investor Day
January 2022
potential to more efficiently develop novel therapeutics by power need and speed years average ats tee | 23andMe
Related slides by other companies
Aeglea BioTherapeutics
Mergers and Acquisitions
June 2023
we aim to develop companion diagnostics to augment our therapeutic combinations and as | Aeglea BioTherapeutics
Aeglea BioTherapeutics
Investor Presentation
September 2023
we aim to develop companion diagnostics to augment our therapeutic combinations and as | Aeglea BioTherapeutics
Aeglea BioTherapeutics
Investor Presentation
July 2023
we aim to develop companion diagnostics to augment our therapeutic combinations and | Aeglea BioTherapeutics
Other recent decks by 23andMe
See all presentations (7 decks)
Investor Presentation
January 2024
Investor Presentation
April 2023
Investor Presentation
August 2022
Investor Presentation
February 2022
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights

Stay in the loop

Join our mailing list to stay in the loop with updates and newest feature releases

Presentations

Start Up
IPO
SPAC
M&A
Investor Day
Results
ESG
Credit
Investment Banking

Explore

Presentation Collections
Slide Collections

Company

Blog
Contact us
© 2021-2024 Slidebook.io